Objective: We aimed to evaluate rates of delivery and clinical manifestations of preterm severe preeclampsia in singleton and twin gestations.
Introduction
Preeclampsia is a heterogeneous syndrome thought to complicate 5 to 8% of pregnancies. 1 At term, the disease is easily managed by delivery of the fetus, although preterm severe disease can present a diagnostic and therapeutic challenge. 2, 3 It is well-established that women with twin pregnancies are at increased risk of hypertensive disorders in pregnancy, [4] [5] [6] [7] [8] [9] however, prior studies have attributed a risk to the entirety of gestation, rather than assessing when rates of disease begin to increase. Thus it is unknown whether twin pregnancies are affected by preeclampsia earlier than are singletons, or with different manifestations of disease. A better understanding of early, severe disease in multiple gestations may aid our ability to care for multifetal pregnancies, and improve our understanding of the pathophysiology of the disease.
We hypothesized that severe preterm preeclampsia would be more common among twin gestations, and that clinical presentation of the disease may differ by twinning status. We therefore, primarily, aimed to compare the rates of delivery for preterm severe preeclampsia between singleton and twin gestations in a large cohort, and secondarily, to compare the clinical manifestations of disease in these two groups.
Methods
We conducted a retrospective cohort study at a single institution including all deliveries of singleton or twin gestations from 2000 to 2009. An institutional database containing demographic, prenatal and intrapartum data was used to identify all women with diagnoses of preeclampsia or hypertension, and delivery between 24 and 0/7 and 36 and 6/7 weeks gestation. For all women who delivered before 37 weeks, and carried a diagnosis of hypertension or preeclampsia, electronic medical records were reviewed. A diagnosis of severe preeclampsia was made based on clinician diagnosis and validated by chart review using American College of Obstetricians and Gynecologists criteria. 1 This included blood pressure >160/110 on two instances at least 6 h apart, symptoms of severe headache, visual changes, epigastric pain, transaminase values greater than twice normal, platelets 100 000, >5 g of proteinuria in 24 h, oliguria (<500 ml in 24 h), severe fetal growth restriction or pulmonary edema. Only women who met the above criteria for severe preeclampsia were included in the study. Patient data including age, gravidity, parity, other intrapartum diagnoses and preeclampsia diagnostic criteria were collected. The presence of hemolysis elevated liver enzymes low platelet count syndrome, clinical diagnosis of placental abruption, eclampsia and fetal criteria such as intrauterine growth restriction (estimated fetal weight <10%), and absent or reversed umbilical artery Doppler flow, and intrauterine fetal death were noted. Owing to heterogeneous prenatal records, it was not possible to determine all medical comorbities.
Patient demographics and intrapartum diagnoses were compared between women with twin and singleton gestations, and between those who delivered from 24 and 31 þ 6 weeks and those from 32 and 36 6/7 weeks. At our institution, severe preeclamptics who qualify for expectant management are delivered at 34 weeks. By using a 32-week threshold, we aimed to capture those patients that did not qualify for expectant management owing to the severity of their disease. The rate of preterm delivery for severe preeclampsia was calculated for all gestational age categories. The proportion of preterm deliveries accounted for by severe preeclampsia was also calculated for twins and singletons at each gestational age category. Finally, we compared the criteria by which patients met the diagnosis of severe preeclampsia. The data were analyzed using STATA 4.0. w 2 tests and student's t-tests were used for comparison, and Yates' correction was applied for low frequencies. Logistic regression was used to identify factors associated with twin gestation among women with severe preeclampsia.
Results
There were 86 765 births during our study period, including 83 310 singletons, 3244 twins and 211 higher-order multiples. There were 6259 preterm deliveries (4672 singletons, 1399 twins, and 188 higherorder multiples). Among those, 352 women with a singleton gestation and 79 women with a twin gestation delivered preterm and had a diagnosis of severe preeclampsia as ascertained by diagnosis at delivery, and validated by chart review utilizing American College of Obstetricians and Gynecologists criteria for diagnosis of severe preeclampsia. The characteristics of women with singleton and twin gestations were compared (Table 1) . Women with a twin gestation were older (mean age 32.7 vs 31.0 years, P ¼ 0.04) than those with a singleton, and had fewer pregnancies and deliveries. 75% of women with a twin gestation were nulliparous compared with 55% of women with a singleton, P<0.001. Gestational age at delivery was the same between groups. African-American women were more likely to have a singleton gestation than a twin gestation (P ¼ 0.015). The majority of patients were delivered via cesarean section, although there was no difference in the cesarean delivery rate between singleton and twin gestations. Women with singleton gestations were more likely than women with twin gestations to have a preexisting diagnosis of chronic hypertension (18% vs 8%, P ¼ 0.03). Women with twins were more likely to have a secondary diagnosis of preterm labor (10% vs 2%, P<0.001).
Logistic regression was used to evaluate factors associated with twining status among the cohort of women with a diagnosis of severe preeclampsia. Potential confounders were evaluated including age, race and chronic hypertension. In a model controlling for chronic hypertension and ethnicity, only race was a significant predictor of twinning status, with African-American women less likely to have a twin gestation (odds ratio 0.28, 95% confidence interval (0.122 to 0.650)).
Next, we evaluated these same characteristics within gestational age categories 24 to 31 6/7 and 32 to 36 6/7 weeks. Among women who delivered between 32 0/7 and 36 6/7 weeks gestation, those with twin gestations were significantly older and had fewer pregnancies and deliveries. Those with twins were more likely to have a diagnosis of preterm labor; 16% vs 2%, P<0.001, among women delivered between 24 and 31 6/7 weeks, and 7% vs 2%, P ¼ 0.066 among women delivered between 32 and 36 6/7 weeks. This difference was only statistically significant in the women who delivered in the earliest gestational age category.
Rates of preterm delivery for severe preeclampsia were calculated and compared (Figure 1 ). Over the entire population of births, women with twins were significantly more likely than those with a singleton to have a preterm delivery for severe preeclampsia (2.4% vs 0.4%, P<0.001), with a relative risk of 5.70 (95% confidence interval 4.47 to 7.26). This was true for women delivering between 24 0/7 and 31 6/7 weeks (0.8% vs 0.2%, P<0.001) and 32 to 36 6/7 weeks (1.7% vs 0.3%, P<0.001).
We evaluated the contribution of severe preeclampsia to preterm birth rates. Among 1905 babies born between 24 0/7 to 31 6/7 Risk of preterm severe preeclampsiaweeks gestation, delivery for severe preeclampsia was equally common between singleton and twin gestations (9% vs 8%, P ¼ 0.53). However, when evaluating those delivered between 32 0/7 and 36 6/7 weeks gestation, the rate of preterm delivery for severe preeclampsia was greater for singletons than twins (7% vs 5%, P ¼ 0.031). Finally, the diagnostic criteria for severe preeclampsia were compared. Rates of HELLP (hemolysis-elevated liver enzymes low platelet count), abruption, eclampsia and fetal criteria were similar between singleton and twin gestations. Women with a twin gestation were more likely to be diagnosed with severe preeclampsia based on lab abnormalities alone (12% vs 3%, P ¼ 0.002). All other categories of diagnostic criteria were similar between twins and singletons. Rates stratified by gestational age are reported in Table 2 .
Discussion
Preterm severe preeclampsia carries high morbidity, and often presents a therapeutic dilemma for clinicians balancing the needs of mother and fetus. The risk of preterm severe preeclampsia has not been well-defined, and it is unknown whether the pathophysiology of preeclampsia in singleton and multiple gestations differs. In this cohort of nearly 87 000 births, twin pregnancies were significantly more likely than singletons to be delivered preterm due to severe preeclampsia. The clinical manifestations of preterm severe preeclampsia appeared to be similar between singleton and twins. Results from this large, population-based cohort may be applicable to other tertiary care centers, and may help further characterize a rare disease process.
The findings seen here are consistent with the large body of work showing increased hypertensive disorders among women with multiple gestations. [4] [5] [6] [7] [8] [9] Sibai et al. 8 reported the rates of severe preeclampsia among twins as high as 6.4%. The rate of 2.4% here is lower, but this is likely explained by the limitation of the current study to preterm disease, and by the larger cohort size. Furthermore, the incidence of preterm severe preeclampsia did not differ by year of delivery within our cohort, supporting the internal validity of our estimates. Our rates of hemolysis elevated liver enzymes low platelet count syndrome and placental abruption are within the previously published estimates. 8, 10 Little literature exists describing the clinical manifestations of preterm severe preeclampsia in either singleton or twin pregnancy. Although this study was underpowered todetect a difference in diagnostic criteria, there did not appear to be significant differences between twin and singleton gestations, with the exception of increased deliveries for laboratory findings only in 32 to 36 þ 6 week twins. This may suggest that the underlying pathophysiology of preterm severe preeclampsia is not altered in the setting of multifetal gestation. Data on how gestational age at onset and twinning status interact is limited, and our study suggests that although women with twins are more likely to develop early severe preeclampsia than women with a singleton gestation, the manifestations of this disease appears similar.
This study has several important limitations. This was a retrospective investigation with the typical constraints on data collection. As such, there are several potential confounders that could not be accounted for, including maternal medical disease (with the exception of chronic hypertension), mode of conception and smoking status. However, the aim of this study was not to assess risk factors for the development of the disease, but rather to describe the incidence of a rare outcome among a large population-based cohort. The contribution of maternal comorbidities to the risk of severe preeclampsia has been established. 11 Our goal was to compare rates and manifestations of disease between singletons and twins. In our cohort, it is unlikely that chronic hypertension or race accounted for the increased risk among women with twin gestations, as the incidence of chronic hypertension and white race were actually greater among women with a singleton. There were differences in age and parity between twins and singletons that could not be controlled for, however, these may be statistical more than clinical. For example, the mean difference in age between groups was <2 years. Also, prior work has suggested that differences in parity do not explain the increased rate of preeclampsia in twins. 12 Finally, our study was limited to women who delivered between 24 0/7 and 36 6/7 weeks gestation, therefore the results may not be applicable to women with severe preeclampsia before viability or at term.
Additional research is needed to investigate the relationship between early severe preeclampsia and multifetal gestation. Prospective studies evaluating the effect of obesity, use of assisted reproductive technology and other possible risk-modifiers of this relationship are needed. Our study provides a description of a rare but morbid disease and its relationship to twin gestations. These findings may be useful in both antenatal surveillance as well as patient counseling.
